However, this Chinese formula focused on the targets associated with AD, such as neurotransmitter release and interaction between neuroactive ligands and receptors (ADRA2C, APP, CASP3, CHRM1, CHRNA7, GABRA1, and CYP2D6). Here, APP is linked to Alzheimer disease.